Announced Mon, 2 Mar · 16:57 IST

Appointment of M/s Panchal S K and Associates as the Statutory Auditor of the Company.

Auditor Resigned MidtermManagement Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Asston Pharmaceuticals has appointed M/s Panchal S K and Associates (Firm Registration No. 145989W) as its new Statutory Auditor, effective 27th February 2026, via a board resolution passed by circulation. The appointment was made on the recommendation of the Audit Committee under Section 175 of the Companies Act, 2013, and is subject to shareholder approval at the next general meeting. The filing notes the appointment fills a 'Casual Vacancy,' implying the previous auditor stepped down before completing their full term. The new firm, established in 2017, is led by founder partner Swati Panchal and serves SMEs and large corporates across industries.

Likely market impact

Routine governance update, but the casual vacancy signals that the prior auditor exited mid-term, which shareholders should monitor for context. The new auditor will need shareholder ratification at the upcoming AGM.